The fix is to verify your concentration before the first injection
Infections increase in some reports, for example yeast or bacterial vaginosis, if the microbial balance changes
[17] [10] Insulin does not cross the placenta in clinically significant amounts, making it the preferred choice for achieving tight glycemic control without direct fetal exposure
If you choose to inject in the same area, always use a different spot in that area, at least 1 inch apart
Tirzepatide (Mounjaro, Zepbound), a dual GIP/GLP-1 receptor agonist, reports injection site reaction rates of approximately 1.7-2.2% in its FDA prescribing information, similar to semaglutide
Clinical rationale: Your doctor must explain why Ozempic, specifically, is the right choice for you, perhaps even arguing why other covered weight loss drugs (if any) are not appropriate